Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
Grigoris Gerotziafas, Professor of Hematology at the Faculty of Medicine, Sorbonne University, Paris, and Head of the Thrombosis Department at Tenon Hospital in Paris, shared an insightful post on LinkedIn:
“We are pleased to share the publication, led by Prof. Alfonso Tafur (Department of Medicine, Vascular Medicine, Endeavor Health, Evanston, Illinois, University of Chicago, USA), of an important article on “Extended anticoagulation in patients with cancer-associated venous thromboembolism.”
This work highlights the challenges and strategies for managing CAT in oncology care and underscores the impact of the API-CAT study on optimizing antithrombotic treatment for patients with cancer-associated thrombosis.
The article emphasizes the urgent need to establish dedicated cancer thrombosis clinics to support shared decision-making and provide tailored management for patients.
We are proud to contribute to this significant initiative in collaboration with:
- CaVITE Thrombosis Center, Centre de Recherche Saint-Antoine (CRSA), INSERM U938, Sorbonne University, Paris, France, and
- Center for Translational Research and Education, Department of Pathology and Laboratory Medicine, Loyola University Stritch School of Medicine, Maywood, Chicago, USA.
Together, we aim to bridge science and clinical practice, delivering patient-centered strategies that enhance diagnosis, treatment, and prognosis for individuals facing cancer-associated thrombosis.”
Read the full article here:
Article: Extended anticoagulation in patients with cancer-associated venous thromboembolism
Authors: Atefeh Ghorbanzadeh, Mateo Porres-Aguilar, Robert McBane, Grigoris Gerotziafas, Alfonso Tafur
Discover the latest developments in coagulation and thrombosis research with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly